Movement Alert｜ASCENTAGE Intraday Rise 13.18%, H1 Revenue Growth and Broker Initiation Drive Rally

Market Focus

Aug 27

On August 27, ASCENTAGE rose 13.18% in regular trading, reaching HKD 37.26 per share, with turnover of HKD 167 million.

The rally was driven by a convergence of positive catalysts. The company reported H1 total revenue of RMB 302 million, up 29% year-over-year, with product sales reaching RMB 282 million, a 33% increase, powered by the dual-engine commercialization of olverembatinib and lisaftoclax. Guotai Haitong Securities initiated coverage with an Overweight rating and a target price of HKD 59.09, projecting full-year revenue of RMB 1.015 billion, representing approximately 77% year-over-year growth. Additionally, CICC maintained its Outperform rating with a HKD 45 target price. The company also recently appointed a Chief Business Officer and Chief Commercial Officer to accelerate global commercialization, while multiple global registrational Phase III trials continue to advance.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/1150187844"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1150187844\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1150187844?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-27 15:59","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1150187844","market":"hk","top_or_hot":-1,"title":"Movement Alert｜ASCENTAGE Intraday Rise 13.18%, H1 Revenue Growth and Broker Initiation Drive Rally","media":"Market Focus","content":"<p><p>On August 27, ASCENTAGE rose 13.18% in regular trading, reaching HKD 37.26 per share, with turnover of HKD 167 million.</p><p>The rally was driven by a convergence of positive catalysts. The company reported H1 total revenue of RMB 302 million, up 29% year-over-year, with product sales reaching RMB 282 million, a 33% increase, powered by the dual-engine commercialization of olverembatinib and lisaftoclax. Guotai Haitong Securities initiated coverage with an Overweight rating and a target price of HKD 59.09, projecting full-year revenue of RMB 1.015 billion, representing approximately 77% year-over-year growth. Additionally, CICC maintained its Outperform rating with a HKD 45 target price. The company also recently appointed a Chief Business Officer and Chief Commercial Officer to accelerate global commercialization, while multiple global registrational Phase III trials continue to advance.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜ASCENTAGE Intraday Rise 13.18%, H1 Revenue Growth and Broker Initiation Drive Rally</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜ASCENTAGE Intraday Rise 13.18%, H1 Revenue Growth and Broker Initiation Drive Rally\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-08-27 15:59</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On August 27, ASCENTAGE rose 13.18% in regular trading, reaching HKD 37.26 per share, with turnover of HKD 167 million.</p><p>The rally was driven by a convergence of positive catalysts. The company reported H1 total revenue of RMB 302 million, up 29% year-over-year, with product sales reaching RMB 282 million, a 33% increase, powered by the dual-engine commercialization of olverembatinib and lisaftoclax. Guotai Haitong Securities initiated coverage with an Overweight rating and a target price of HKD 59.09, projecting full-year revenue of RMB 1.015 billion, representing approximately 77% year-over-year growth. Additionally, CICC maintained its Outperform rating with a HKD 45 target price. The company also recently appointed a Chief Business Officer and Chief Commercial Officer to accelerate global commercialization, while multiple global registrational Phase III trials continue to advance.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06855","symbol_name":"亚盛医药","start_time":0,"source_url":"","article_id":"1150187844","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1150187844","pubTimestamp":1787817591,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On August 27, ASCENTAGE rose 13.18% in regular trading, reaching HKD 37.26 per share, with turnover of HKD 167 million.The rally was driven by a convergence of positive catalysts. The company...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06855":"亚盛医药"},"translate_title":"走势提醒|亚盛盘中上涨13.18%，上半年收入增长和经纪商启动推动反弹","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06855":1},"content_text":"On August 27, ASCENTAGE rose 13.18% in regular trading, reaching HKD 37.26 per share, with turnover of HKD 167 million.The rally was driven by a convergence of positive catalysts. The company reported H1 total revenue of RMB 302 million, up 29% year-over-year, with product sales reaching RMB 282 million, a 33% increase, powered by the dual-engine commercialization of olverembatinib and lisaftoclax. Guotai Haitong Securities initiated coverage with an Overweight rating and a target price of HKD 59.09, projecting full-year revenue of RMB 1.015 billion, representing approximately 77% year-over-year growth. Additionally, CICC maintained its Outperform rating with a HKD 45 target price. The company also recently appointed a Chief Business Officer and Chief Commercial Officer to accelerate global commercialization, while multiple global registrational Phase III trials continue to advance.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}